| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 5.97B | 5.45B | 5.35B | 6.25B | 4.80B |
| Gross Profit | 1.21B | 1.25B | 1.34B | 1.23B | 614.72M |
| EBITDA | 936.14M | 1.12B | 1.21B | 1.03B | 448.51M |
| Net Income | 692.90M | 738.50M | 829.85M | 687.10M | 193.56M |
Balance Sheet | |||||
| Total Assets | 5.55B | 4.96B | 4.61B | 4.38B | 4.20B |
| Cash, Cash Equivalents and Short-Term Investments | 1.80B | 1.61B | 1.39B | 761.64M | 601.15M |
| Total Debt | 121.45M | 142.98M | 125.51M | 256.88M | 298.39M |
| Total Liabilities | 1.34B | 998.42M | 933.80M | 1.18B | 1.53B |
| Stockholders Equity | 4.20B | 3.96B | 3.68B | 3.21B | 2.67B |
Cash Flow | |||||
| Free Cash Flow | 651.71M | 541.14M | 1.08B | 420.98M | 11.14M |
| Operating Cash Flow | 859.62M | 744.79M | 1.16B | 621.41M | 210.09M |
| Investing Cash Flow | -79.04M | -203.66M | -71.95M | -78.29M | -204.06M |
| Financing Cash Flow | -535.00M | -379.21M | -489.05M | -233.73M | -101.83M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | HK$207.03B | 18.02 | 69.31% | 0.44% | 185.41% | 308.79% | |
70 Outperform | HK$4.99B | 8.02 | 19.99% | 7.41% | 9.62% | -6.18% | |
65 Neutral | HK$1.59B | 8.40 | 4.75% | 6.25% | -1.22% | -38.58% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
61 Neutral | HK$1.10B | -2.83 | -8.76% | 9.09% | -39.09% | 5.19% | |
60 Neutral | HK$554.60M | -30.67 | 1.26% | 13.73% | -45.00% | -111.66% | |
43 Neutral | HK$190.12M | -0.96 | -10.60% | ― | 2.17% | -1.53% |